Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

I-Acute Lymphoblastic Leukemia (T-ALL)-05

Isigulana: Ongaziwayo

Isini: Indoda

Ubudala: Uneminyaka eli-15 ubudala

Ubuzwe: IsiTshayina

Uxilongo:I-Acute Lymphoblastic Leukemia (T-ALL)

    Ukuxolelwa kwesigulana se-T-ALL esibuyele kwisimo saso esine-Central Nervous System Leukemia Emva koNyango lwe-CAR-T


    Eli tyala libandakanya inkwenkwe eneminyaka eli-16 ubudala evela kuMantla-mpuma eTshayina, enengxaki enkulu ukusukela oko yafunyaniswa ukuba ine-leukemia kunyaka ophelileyo.


    Ngomhla wesi-8 kweyeNkanga, ngo-2020, uDawei (igama elingelolakhe) watyelela isibhedlele sasekuhlaleni ngenxa yokuqina kobuso, ukurhawuzelela, kunye nomlomo ogobileyo. Wafunyaniswa ukuba une-"acute lymphoblastic leukemia (uhlobo lwe-T-cell)." Emva kwekhosi enye ye-induction chemotherapy, i-MRD (isifo esincinci esisele) ayizange ifumaneke, yalandelwa yi-chemotherapy eqhelekileyo. Ngeli xesha, ukubhobozwa komongo wethambo, ukubhobozwa kwe-lumbar, kunye nokufakwa ngaphakathi kwe-thecal akubonisi ziphazamiso.


    Ngomhla wesi-6 kuCanzibe, ngo-2021, kwenziwa utyando lwe-lumbar puncture nge-intrathecal injection, kwaye uhlalutyo lwe-cerebrospinal fluid (CSF) lwaqinisekisa "i-central nervous system leukemia." Oku kwalandelwa ziikhosi ezimbini ze-chemotherapy eqhelekileyo. Ngomhla woku-1 kuJuni, utyando lwe-lumbar puncture nge-CSF puncture lwabonisa iiseli ezingavuthwanga. Utyando lwe-lumbar punctures ezintathu ezongezelelweyo nge-intrathecal injections lwenziwa, kwaye uvavanyo lokugqibela lwe-CSF alubonisanga ziseli ze-tumor.


    Ngomhla wesi-7 kweyeKhala, uDawei wabona iliso lakhe lasekunene liphelelwa kukubona, nto leyo eyabangela ukuba lingaboni kakuhle kuphela. Emva kokusebenzisa i-chemotherapy enzulu, umbono wakhe wasekunene wabuyela kwimeko yesiqhelo.


    Ngomhla wesi-5 ku-Agasti, umbono wakhe weliso lasekunene waphinda waba mandundu, nto leyo eyakhokelela ekubeni angaboni ngokupheleleyo, kwaye iliso lakhe lasekhohlo laba luzizi. Ukususela ngomhla we-10 ukuya kowe-13 ku-Agasti, wenziwa unyango lwe-radiotherapy (TBI) olusebenzisa ingqondo yonke kunye nomqolo, nto leyo eyabuyisela umbono kwiliso lakhe lasekhohlo, kodwa iliso lasekunene lahlala lingaboni. Ngomhla we-16 ku-Agasti, i-MRI scan yobuchopho yabonisa ukuphucuka okuncinci ekuqineni kwe-optic nerve yasekunene kunye ne-chiasm, kwaza kwabonwa ukuphucuka. Akukho zimpawu okanye ukuphucuka okungaqhelekanga okufunyenweyo kwi-brain parenchyma.


    Ngeli xesha, usapho lwalulungiselele ukufakelwa umongo wethambo, lulinde ibhedi kuphela kwigumbi lokufakelwa. Ngelishwa, uhlolo oluqhelekileyo lwangaphambi kokufakelwa lutyhile iingxaki ezenza ukuba ukufakelwa kube nzima.

    2219

    Ngomhla wama-30 ku-Agasti, kwenziwa utyando lokubhoboza umongo wethambo, kwafunyaniswa ukuba kukho i-MRD yomongo wethambo ene-T lymphocytes ezingaqhelekanga ezimalunga nama-61.1%. Utyando lokubhoboza i-lumbar ngenaliti ye-intrathecal nalo lwenziwa, kwaboniswa i-CSF MRD ene-127 iyonke yeeseli, apho ii-T lymphocytes ezingaqhelekanga zaziyi-35.4%, nto leyo ebonisa ukuphinda kwe-leukemia.

    Ngomhla wama-31 ku-Agasti 2021, uDawei nosapho lwakhe bafika kwiziko lethu le-CGT. Uvavanyo lwegazi lokungeniswa lubonise oku: WBC 132.91×10^9/L; umahluko wegazi elingaphandle (imo): 76.0% ukuqhuma. I-induction chemotherapy yanikwa ikhosi enye.

    Emva kokuphonononga unyango lukaDawei lwangaphambili, kwacaca ukuba i-T-ALL yakhe yayingasasebenzi kakuhle/iphinde yabuyela umva kwaye iiseli zethumba zazingene ebuchotsheni, zichaphazela i-optic nerve. Iqela lezonyango lifumanise ukuba uDawei wayehlangabezana neemfuno zokubhalisa kuvavanyo lweklinikhi lwe-CD7 CAR-T.

    Ngomhla we-18 kuSeptemba, kwenziwa olunye uvavanyo: umahluko wegazi elisecaleni (imo) ubonise ukuqhuma kwe-11.0%. Ii-lymphocyte zegazi ezisemacaleni ziqokelelwe ukuze kukhuliswe i-CD7 CAR-T cell culture ngaloo mini inye, kwaye inkqubo yahamba kakuhle. Emva kokuqokelelwa, kwenziwa i-chemotherapy ukulungiselela i-CD7 CAR-T cell immunotherapy.

    Ngexesha le-chemotherapy, iiseli ze-tumor zanda ngokukhawuleza. Ngo-Okthobha 6, umahluko wegazi elisecaleni (i-morphology) ubonise ukuqhuma kwe-54.0%, kwaye inkqubo ye-chemotherapy yalungiswa ukuze kuncitshiswe umthwalo we-tumor. Ngo-Okthobha 8, uhlalutyo lwe-morphology yeseli ye-bone marrow cell lubonise ukuqhuma kwe-30.50%; i-MRD ibonise ukuba i-17.66% yeeseli yayizi-T lymphocytes ezingekavuthwa kakuhle.

    Ngomhla we-9 kweyeDwarha, iiseli ze-CD7 CAR-T zaphinda zafakwa. Emva kokufakwa kwakhona, isigulane safumana umkhuhlane ophindaphindiweyo kunye nentlungu yeentsini. Nangona unyango oluphuculweyo lokulwa nosulelo, umkhuhlane awuzange ulawulwe kakuhle, nangona iintlungu zeentsini zaphela kancinci kancinci.

    Ngomhla we-11 emva kokufakwa kwakhona kwegazi, ukuqhuma kwegazi elingaphandle kwemithambo yegazi kwanda ukuya kwi-54%; ngomhla we-12, uvavanyo lwegazi lwabonisa ukuba iiseli ezimhlophe zegazi zinyuka ziye kwi-16×10^9/L. Ngomhla we-14 emva kokufakwa kwakhona kwegazi, isigulana saba ne-CRS enzima, kuquka umonakalo wentliziyo, ukungasebenzi kakuhle kwesibindi nezintso, ukungabikho koxinzelelo lwegazi emzimbeni, ukopha okuphantsi kwamathumbu, kunye nokuxhuzula. Unyango olunamandla oluneempawu noluxhasayo, kunye nokutshintshiselana ngeplasma, luphucule kancinci ukusebenza kwamalungu omzimba achaphazelekayo, luzinzisa iimpawu ezibalulekileyo zesigulana.

    Ngomhla wama-27 kweyeDwarha, isigulana sasinamandla emisipha angaphantsi kwebanga eli-0. Ngomhla wama-29 kweyeDwarha (iintsuku ezingama-21 emva kokufakelwa kwakhona), uvavanyo lwe-MRD lomongo lwajika lwaba negative.

    Ekwimeko yokululama ngokupheleleyo, uDawei womeleza ukusebenza kwemilenze yakhe esezantsi ngoncedo lwabahlengikazi kunye nosapho, kancinci kancinci wabuyisela amandla emisipha ukuya kumabakala ama-5. Ngomhla wama-22 kweyeNkanga, watshintshelwa kwicandelo lokufakelwa izicubu ukuze alungiselele ukufakelwa iseli ye-hematopoietic stem.

    inkcazo2

    Submit An Free Inquiry

    Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

    AI Helps Write